Furthermore, the PBMCs from patients with RA included a high proportion of both CD14+ CD86+ M1 and CD14+ CD206+ M2 macrophages compared with healthy controls (Figure 5c). This evidence concerns the gene CD86 and rheumatoid arthritis.